US Biopharma Co Syneos Health Opens 137,000 Sq Ft Global Life Sciences and Technology Centre in Hyderabad

Syneos Health has opened a 137,000 sq ft Global Life Sciences and Technology Centre in Hyderabad, with an initial workforce of more than 700 professionals, as the US-based biopharmaceutical solutions company expands the city’s role as a global hub for life sciences, clinical research, technology, and AI.

The centre is Syneos Health’s largest facility in Asia and third-largest globally, and will bring together capabilities spanning clinical development, commercialisation, medical affairs, technology, AI, and corporate functions. The workforce is expected to expand over the coming years as the company builds specialised capabilities from Hyderabad for its global operations.

The facility comes as Hyderabad strengthens its position as a major healthcare and life sciences GCC destination. The city accounts for an estimated 20–23% of India’s healthcare-biotech GCC market, supported by Telangana’s broader ecosystem spanning APIs, bulk drugs, generics, CDMOs, vaccines, research, and drug discovery.

Syneos Health is positioning the Hyderabad centre as more than a traditional delivery centre, with global leaders, clinical and commercial specialists, technologists, and AI teams working from the city to support drug development and commercialisation for customers worldwide.

“Beyond building capabilities, we are bringing together leaders, experts and innovators who are helping redefine how work gets done, creating smarter approaches to drug development and commercialisation for customers around the world,” Tom Wollman, Head of Operational Excellence, Syneos Health, said in a statement.

Syneos Health’s expansion also adds to Hyderabad’s growing concentration of global contract research organisations. With Syneos Health’s presence, four of the world’s top five CROs now have operations in Hyderabad. Global healthcare and pharmaceutical companies including MSD, Sanofi, Bristol Myers Squibb, Eli Lilly and Amgen have also been expanding capabilities across Telangana’s life sciences value chain, spanning R&D, clinical development, data, technology and AI.

Telangana IT Minister D Sridhar Babu said Hyderabad’s existing life sciences and technology strengths create an opportunity to build AI-enabled healthcare capabilities.

“Hyderabad has built one of India’s strongest life sciences ecosystems and one of its deepest technology talent pools. The next opportunity is to bring these strengths together with AI,” D Sridhar Babu, Minister for Information Technology, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Government of Telangana said. 

“With an end-to-end ecosystem spanning APIs, bulk drugs, generics, CDMO, vaccines, research and discovery, and a growing concentration of global healthcare and biotech GCCs, Hyderabad has the talent and depth to become a global testbed for AI-enabled life sciences,” he added.

Syneos Health said the Hyderabad centre will serve as a strategic growth hub where teams across clinical, commercial, technology, and scientific functions collaborate on global projects.

“This is far more than a new office. It is a strategic hub where global leaders, clinical and commercial experts, and technologists and innovators are helping shape the future of healthcare, while delivering better outcomes for biopharmaceutical customers,” Jinu Jose, General Manager, India and Strategic Growth Hubs, Syneos Health, noted.